The Problem
Growth hormone production peaks in your 20s and declines at roughly 14–15% per decade thereafter. By your 40s, GH pulsatility is significantly blunted. The downstream effects are measurable, progressive, and — with the right intervention — addressable.
You sleep 7–8 hours but wake unrefreshed. Slow-wave sleep — the stage where GH is primarily secreted — degrades with age. Less deep sleep means less GH. Less GH means less deep sleep. Ipamorelin interrupts this cycle.
You're training and eating well but body composition won't shift. Growth hormone decline after 30 changes how your body partitions energy — favoring fat storage over lean mass maintenance.
Workouts that used to leave you energized now leave you depleted for days. GH drives tissue repair, collagen synthesis, and cellular regeneration. Blunted GH pulsatility means blunted recovery.
The Mechanism
Most GH-related compounds work by flooding the system — either injecting GH directly or stimulating broad, non-selective release. Ipamorelin is different: it selectively binds the GHSR-1a receptor without activating the pathways that raise cortisol, prolactin, or appetite. The result is clean, pulsatile GH release that your body recognizes as its own.
Signal Cascade
Selectivity Comparison
Clinical Evidence
Ipamorelin's effects are documented across peer-reviewed studies, clinical pharmacology data, and comparative secretagogue research. Each pathway below is supported by a specific citation.
Ipamorelin's primary GH pulse occurs 30–60 minutes after administration, coinciding with the onset of slow-wave sleep. Clinical data show measurable increases in slow-wave sleep duration and GH secretion amplitude in treated subjects.
Source: Raun K et al. Eur J Endocrinol. 1998;139(5):552–561.
GH secretagogues consistently improve lean-to-fat ratio. Ipamorelin's selectivity — it does not raise cortisol or prolactin — makes it particularly well-suited for body composition protocols where hormonal side effects must be minimized.
Source: Bowers CY et al. J Clin Endocrinol Metab. 1990;70(4):975–982.
GH drives IGF-1 synthesis, which mediates collagen production, satellite cell activation, and musculoskeletal repair. Athletes and active patients report measurable reductions in recovery time within 4–8 weeks of protocol initiation.
Source: Nass R et al. Ann Intern Med. 2008;149(9):601–611.
GH receptors are expressed throughout the brain, including hippocampus and prefrontal cortex. Restoring pulsatile GH release via selective secretagogues has been associated with improvements in working memory and processing speed.
Source: Nyberg F. Curr Opin Investig Drugs. 2000;1(2):246–250.
Ipamorelin improves insulin sensitivity and lipid profiles through GH-mediated lipolysis and hepatic IGF-1 upregulation. Unlike ghrelin mimetics (MK-677), Ipamorelin does not significantly increase appetite or worsen glucose metabolism.
Source: Raun K et al. Eur J Endocrinol. 1998;139(5):552–561.
The Protocol
Designed around physician oversight, baseline labs, pharma-grade compound, and quantified outcomes at 4, 8, and 12 weeks. No guesswork. No shortcuts.
Pricing
Anti-aging clinic protocols for GH optimization typically run $800–$1,500/month when you factor in office visits, lab fees, and compound costs billed separately. Aurelius bundles everything into a single monthly plan.
IpamorelinRx Plan
vs. $800–$1,500/mo at an anti-aging clinic
Check My EligibilityNo commitment. Cancel anytime.
Eligibility Screening
This 6-question screen checks for Ipamorelin-specific contraindications. It takes under 60 seconds and does not constitute a medical evaluation.
1.Do you have a known pituitary tumor or structural pituitary disorder?
2.Have you been diagnosed with or treated for cancer in the past 5 years?
3.Is your most recent HbA1c above 8.0%?
4.Are you currently pregnant or planning to become pregnant?
5.Are you primarily concerned with sleep quality, energy, body composition, recovery, or cognitive performance?
6.Are you willing to self-administer a subcutaneous injection once daily?
Frequently Asked Questions
Including the Ipamorelin vs. GHRP-6 vs. MK-677 comparison, safety profile, off-label prescribing, and injection technique.

Start Today
Ipamorelin is the most selective GH secretagogue available. A physician-supervised protocol is available today. The question is whether you're a candidate.
† This page describes off-label use of Ipamorelin, a research peptide. Ipamorelin is not FDA-approved for any specific indication. Off-label prescribing is legal and at the clinical discretion of a licensed physician. This content is for informational purposes only and does not constitute medical advice. Individual results vary.